PharmTech Drug Digest 11.20
News|Articles|August 6, 2013

Emerging Pharma Leaders Tapped by Pharmaceutical Executive Magazine

Selected trendsetters reflect changes in the pharmaceutical industry.

Pharmaceutical Executive, a sister publication of Pharmaceutical Technology,  presented 15 winners in its annual Emerging Pharma Leaders competition in its July issue.

The 15 trendsetters reflect an industry that is changing from Big Pharma to what Pharmaceutical Executive characterizes as growing to be small.

For the first time, we include line executives from generic medicines and vaccines, two adjacent business units which under turbulent market conditions have emerged as key sources of product and process innovation, says Editor William Looney. Several of this year's winners have graduated to new roles that reflect the growing importance the 'c suite' places on knowledge retention, information services and the seeding of skills and talent throughout the organization.”

Other recipients hold positions that reflect the need for active, institutionalized collaboration between the RD and commercial product teams, at the earliest stage of the development cycle,:” Looney adds. And in a business where customer insight is still in short supply, we find more leaders are entering the industry with valuable outside exposure to the fickle affiliations of the retail trade.

The winners can be viewed on the Pharmaceutical Executive website.


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.